146 related articles for article (PubMed ID: 3493845)
61. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
Mayumi H; Good RA
Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882
[TBL] [Abstract][Full Text] [Related]
62. Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. II. Selective inactivation of hapten-reactive suppressor T cells by hapten-nonimmunogenic copolymers of D-amino acids, and its application to the study of suppressor T-cell effect on helper T-cell development.
Hamaoka T; Yoshizawa M; Yamamoto H; Kuroki M; Kitagawa M
J Exp Med; 1977 Jul; 146(1):91-106. PubMed ID: 68995
[TBL] [Abstract][Full Text] [Related]
63. Abrogation of the capacity of delayed-type hypersensitivity responses to alloantigens by intravenous injection of neuraminidase-treated allogeneic cells.
Sano S; Suda T; Qian JH; Sato S; Ikegami R; Hamaoka T; Fujiwara H
J Immunol; 1987 Dec; 139(11):3652-9. PubMed ID: 3680947
[TBL] [Abstract][Full Text] [Related]
64. Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route.
Sato S; Qian JH; Kokudo S; Ikegami R; Suda T; Hamaoka T; Fujiwara H
J Immunol; 1988 Feb; 140(3):717-22. PubMed ID: 2448373
[TBL] [Abstract][Full Text] [Related]
65. Immunological tolerance in bone marrow-derived lymphocytes. I. Evidence for an intracellular mechanism of inactivation of hapten-specific precursors of antibody-forming cells.
Katz DH; Hamaoka T; Benacerraf B
J Exp Med; 1972 Dec; 136(6):1404-29. PubMed ID: 4539311
[TBL] [Abstract][Full Text] [Related]
66. Alteration of cell-surface antigenicity of the mouse plasmacytoma. II. Lack of correlation between synthesis of myeloma protein and alteration of surface antigen.
Ohno S; Natsu-ume-Sakai S; Migita S
J Natl Cancer Inst; 1977 Feb; 58(2):229-37. PubMed ID: 833874
[TBL] [Abstract][Full Text] [Related]
67. Enrichment of antitumor effector cells that are effective in vivo from spleen cells of tumor-bearing mice through the use of Dolichos biflorus lectin.
Okada T; Ezawa K; Imai Y; Osawa T
Cancer Res; 1986 Nov; 46(11):5611-7. PubMed ID: 3093067
[TBL] [Abstract][Full Text] [Related]
68. Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity.
Kennedy RC; Shearer MH; Lowe DB; Jumper CA; Chiriva-Internati M; Bright RK
Cancer Immunol Immunother; 2004 Nov; 53(11):987-94. PubMed ID: 15156293
[TBL] [Abstract][Full Text] [Related]
69. Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells.
Powell TJ; Streilein JW
J Immunol; 1990 Feb; 144(3):854-9. PubMed ID: 2136901
[TBL] [Abstract][Full Text] [Related]
70. The mechanism of tolerance induction of tumor-specific delayed-type hypersensitivity responses by intravenous inoculation of tumor cells.
Sato S; Fukuzawa M; Nakajima H; Ogata M; Kosugi A; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1985 Nov; 76(11):1099-106. PubMed ID: 2935516
[TBL] [Abstract][Full Text] [Related]
71. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
Miller SD; Butler LD
J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
[TBL] [Abstract][Full Text] [Related]
72. [Tumor-specific immunotherapy: active immunotherapy by augmenting the induction of tumor-specific effector T cells through a T-T cell interaction mechanism].
Kosugi A; Fujiwara H; Hamaoka T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1527-35. PubMed ID: 6236750
[TBL] [Abstract][Full Text] [Related]
73. The role of L3T4-positive T lymphocytes in the generation of anti-tumor immunity in the mouse.
Yamamoto H; Takata M; Fujimoto S
Jpn J Cancer Res; 1987 Feb; 78(2):176-84. PubMed ID: 2951356
[TBL] [Abstract][Full Text] [Related]
74. Hapten-specific tolerance induced by hapten conjugates of D-glutamic acid, D-lysine (D-Gl) or isologous gamma-globulin: evidence for central B cell tolerance in the presence of carrier-primed helper T cells.
Katz DH; Borel Y
J Immunol; 1978 Jun; 120(6):1824-7. PubMed ID: 77880
[TBL] [Abstract][Full Text] [Related]
75. Regulatory function for murine intraepithelial lymphocytes. Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance.
Fujihashi K; Taguchi T; McGhee JR; Eldridge JH; Bruce MG; Green DR; Singh B; Kiyono H
J Immunol; 1990 Oct; 145(7):2010-9. PubMed ID: 1975820
[TBL] [Abstract][Full Text] [Related]
76. Enhancement of carrier-specific helper T cell function by the synthetic adjuvant, N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
Sugimoto M; Germain RN; Chedid L; Benacerraf B
J Immunol; 1978 Mar; 120(3):980-2. PubMed ID: 344799
[TBL] [Abstract][Full Text] [Related]
77. Contrasuppressor cells that break oral tolerance are antigen-specific T cells distinct from T helper (L3T4+), T suppressor (Lyt-2+), and B cells.
Kitamura K; Kiyono H; Fujihashi K; Eldridge JH; Green DR; McGhee JR
J Immunol; 1987 Nov; 139(10):3251-9. PubMed ID: 3500210
[TBL] [Abstract][Full Text] [Related]
78. Tolerance induction in B lymphocytes but thymus-dependent antigens. T cells may abrogate B-cell tolerance induction by prevent an antibody response.
Schrader JW
J Exp Med; 1975 May; 141(5):974-89. PubMed ID: 47898
[TBL] [Abstract][Full Text] [Related]
79. Specific, transient suppression of the immune response by HGG tolerant spleen cells. II. Effector cells and target cells.
Doyle MV; Parks E; Weigle WO
J Immunol; 1976 Oct; 117(4):1152-8. PubMed ID: 61992
[TBL] [Abstract][Full Text] [Related]
80. Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers.
Mokyr MB; Barker E
Cancer Immunol Immunother; 1986; 23(1):11-9. PubMed ID: 3490305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
